A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study.
The test, which improves risk assessment when patients are first diagnosed, can also aid in determining which men are suitable for active surveillance – a way of managing the disease without direct treatment.
For the full story from UCSF click here to read more
NBC Nightly News | May 08, 2013
New prostate cancer test may prevent overtreatment
By engaging in active surveillance, experts say, doctors can better understand whether or not it’s safe for men to go untreated for prostate cancer. There are several tests that already predict how dangerous a tumor is, but a new test from the company Genomic Health provides doctors with more information by analyzing multiple genes. NBC’s Richard Bazell reports.
HealthWatch: Genetic Test Fives Clue To Dangers Of Prostate Cancer
UCSF doctor Peter Carroll headed up a study that took a look at how a new test – designed by Redwood City’s Genomic Health – analyzes certain genes from a tumor to determine its risk of rapid growth. Allen Martin reports.
Other news coverage:
The Associated Press
San Francisco Chronicle